Skip to content

Genprex, Inc.: 10-Q filed 2026-08-14

What Genprex, Inc. reported in its quarterly report filed 2026-08-14 (fiscal Q2 2026): 21 published measures, 60 facts as tagged in accession 0001437749-26-027846.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-14
Fiscal period
fiscal Q2 2026
Accession
0001437749-26-027846 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Genprex, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-3017,136,916USD
At 2025-12-3110,159,010USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-302,341,864USD
At 2025-12-312,197,134USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-3014,795,052USD
At 2026-03-3116,930,270USD
At 2025-12-317,961,876USD
At 2025-06-301,391,197USD
At 2025-03-313,867,855USD
At 2024-12-311,620,155USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2026-06-3015,154,203USD
At 2025-12-317,830,855USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-4,447,219USD91
2026-01-01 to 2026-06-30-8,909,114USD181
2026-01-01 to 2026-03-31-4,461,895USD90
2025-04-01 to 2025-06-30-4,674,901USD91
2025-01-01 to 2025-06-30-8,639,502USD181
2025-01-01 to 2025-03-31-3,964,601USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-8,277,156USD181
2025-01-01 to 2025-06-30-8,025,661USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-3015,600,504USD181
2025-01-01 to 2025-06-307,770,844USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-179,937,510USD
At 2025-12-31-171,028,396USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2026-04-01 to 2026-06-30473,162shares91
2026-01-01 to 2026-06-30395,122shares181
2025-04-01 to 2025-06-3025,229shares91
2025-01-01 to 2025-06-3019,645shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-9.4USD/shares91
2026-01-01 to 2026-06-30-22.55USD/shares181
2025-04-01 to 2025-06-30-185.3USD/shares91
2025-01-01 to 2025-06-30-439.78USD/shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-4,483,984USD91
2026-01-01 to 2026-06-30-8,978,168USD181
2025-04-01 to 2025-06-30-4,681,784USD91
2025-01-01 to 2025-06-30-8,651,075USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-3015,842,835USD
At 2025-12-318,356,782USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-302,341,864USD
At 2025-12-312,174,634USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,683,471USD91
2026-01-01 to 2026-06-305,429,416USD181
2025-04-01 to 2025-06-302,499,495USD91
2025-01-01 to 2025-06-305,039,489USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-30506,218shares
At 2025-12-31149,811shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30194,732,056USD
At 2025-12-31178,990,122USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2026-06-301,294,081USD
At 2025-12-311,802,228USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2026-06-30688,632USD
At 2025-12-31525,927USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-301,800,513USD91
2026-01-01 to 2026-06-303,548,752USD181
2025-04-01 to 2025-06-302,182,289USD91
2025-01-01 to 2025-06-303,611,586USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2026-01-01 to 2026-06-3054,034USD181
2025-01-01 to 2025-06-305,099USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2026-01-01 to 2026-06-3015,600,504USD181
2025-01-01 to 2025-06-307,770,844USD181

Inspect the source

Entity
Genprex, Inc. / CIK 0001595248
Captured
2026-09-20T09:24:36.735Z
SEC response SHA-256
ff6d5e742455c96504a7a58523e15414997bb596db8f22e2c3e1e53b48f9b5ea

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001595248.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))